Association Between Copayment Amount and Filling of Medications for Angiotensin Receptor Neprilysin Inhibitors in Patients With Heart Failure

Background Angiotensin receptor neprilysin inhibitors (ARNI) reduce mortality and hospitalization for patients with heart failure. However, relatively high copayments for ARNI may contribute to suboptimal adherence, thus potentially limiting their benefits. Methods and Results We conducted a retrosp...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of the American Heart Association Ročník 11; číslo 24; s. e027662
Hlavní autori:	Mukhopadhyay, Amrita, Adhikari, Samrachana, Li, Xiyue, Dodson, John A., Kronish, Ian M., Shah, Binita, Ramatowski, Maggie, Chunara, Rumi, Kozloff, Sam, Blecker, Saul
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England John Wiley and Sons Inc 20.12.2022 Wiley
Predmet:	Angiotensin Receptor Antagonists - therapeutic use angiotensin receptor‐neprilysin inhibitor Biphenyl Compounds - therapeutic use copayment Drug Combinations Heart Failure Humans medication adherence Neprilysin - antagonists & inhibitors Original Research out‐of‐pocket cost Retrospective Studies sacubitril‐valsartan Stroke Volume Tetrazoles - therapeutic use Treatment Outcome Valsartan - therapeutic use Ventricular Function, Left heart failure medication adherence out‐of‐pocket cost sacubitril‐valsartan angiotensin receptor‐neprilysin inhibitor copayment
ISSN:	2047-9980, 2047-9980
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!